巴斯科姆帕尔默眼科研究所第22届新生血管年会

学术会议8个月前发布学术分享者

405 0 0

巴斯科姆帕尔默眼科研究所第22届新生血管年会

◆ 会议时间：2025年2月8日
◆ 会议地点：虚拟会议

◆ 会议简介：

巴斯科姆帕尔默眼科研究所(Bascom Palmer Eye Institute)诚挚地邀请您参加将于2025年2月8日举行的第二二届年度新生血管会议。大会科学计划将由众多杰出的基础科学家、临床医生和医疗专家组成，他们都专注于对眼部新生血管和渗出性疾病的认识和治疗。新生血管会议是专为视网膜专家、普通眼科医生和研究人员而设计。

巴斯科姆帕尔默眼科研究所(Bascom Palmer Eye Institute)是佛罗里达州迈阿密大学米勒医学院( University of Miami Miller School of Medicine)的附属眼科中心，其使命是通过富有同情心的患者护理和创新的研究，通过改善视力，预防失明和增进眼科知识来宣提高生活质量。巴斯科姆帕尔默眼科研究所已经连续19年在《美国新闻与世界报道》“全美最佳眼科医院”评选中位列第1名。巴斯科姆帕尔默眼科研究所凭借最佳眼科医院、最佳临床和住院医师培训项目，眼科时讯（Ophthalmology Times）在全美眼科方面对Bascom Palmer评价极高，并被评为“美国最佳综合眼科项目”。此外，Bascom Palmer研究所的诸多医生也荣登“全美最佳医生”排行榜，他们每年处理超过25万例眼科疾病。未经本站许可禁止复制转载镜像本站任何内容-领域国际医学会议网。

22nd Annual Angiogenesis Meeting – Bascom Palmer Eye Institute

Date: February 8, 2025
Venue: Virtual

Angiogenesis, Exudation, and Degeneration 2025 – Virtual Edition

February 8, 2025

Bascom Palmer Eye Institute invites you to join us in February 2025 for our 22nd annual angiogenesis meeting. This unique and exciting symposium entitled Angiogenesis, Exudation, and Degeneration 2025 will be held virtually on February 8, 2025. The program will feature an exceptional group of basic scientists, clinician scientists, and healthcare experts, all focused on understanding and treating neovascular, exudative, and degenerative diseases of the eye. The program will highlight the revolutionary therapies now in development and clinical practice for the management of non-exudative AMD, exudative AMD, diabetic retinopathy with and without macular edema, retinopathy of prematurity, and inherited retinal degenerations with a special emphasis on the present and future impact of these therapies on clinical practices.

COURSE DESCRIPTION

Angiogenesis 2025 follows the tradition of excellence established by Bascom Palmer’s widely acclaimed Angiogenesis programs between 2004 and 2024. Designed for retina specialists, general ophthalmologists and researchers, the current program will review the latest in imaging, translational research, and clinical trials with an emphasis on how these results will impact clinical ophthalmology. We will emphasize investigator-initiated research and recently completed clinical trials focused on the diagnosis and treatment of a wide range of retinal diseases with special emphasis on age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases.

注册费：

Conference Fees

Registration fee is $200

Registration Deadline

All registrations must be received no later than Thursday, February 6th, 2025 at 3:00 pm (ET).

Cancellation Policy

Conference tuition, less a $25 cancellation fee, is refundable if notice is received on or before January 31, 2025. No refunds shall be considered after January 31, 2025.